MetaSight Diagnostics
PrivateLast Round
Series A
Nov 13, 2024
Total Funding Raised
$8M
Momentum Score
25 /100
Company Overview
MetaSight Diagnostics is a health technology company that creates affordable and precise liquid biopsy diagnostics for early detection of a variety of chronic and acute diseases, utilizing proprietary mass spectrometry technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MetaSight Diagnostics Comps
Public and private peers based on sector, stage, and business model.
MetaSight Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 13, 2024 |
MetaSight Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| aMoon Growth Fund II | Series A |
| Arc Ventures | Series A |
| Saban Ventures | Series A |
| Alumni Ventures | Series A |
MetaSight Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MetaSight Diagnostics's valuation, stock price, and market status.
